Loretta J. Nastoupil

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.6K citations · Full text

Immunohematology, Cancer Immunosurveillance, Autoimmune Disease +15

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Michael D. Jain, Lei Feng et al. · Journal of Clinical Oncology · 2020 · 752 citations · Full text

Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas

Qing Deng, Guangchun Han, Nahum Puebla‐Osorio et al. · Nature Medicine · 2020 · 561 citations · Full text

Lymphoid Neoplasia, Radiation Oncology, Cell Therapy +10

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Nathan Fowler, Michael Dickinson, Martin Dreyling et al. · Nature Medicine · 2021 · 492 citations · Full text

Lymphoid Neoplasia, Hematology, Immunology +6

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Mark W. Clemens, L. Jeffrey Medeiros, Charles E. Butler et al. · Journal of Clinical Oncology · 2015 · 414 citations · Full text